VISCOSUPPLEMENTATION is a safe nonsurgical approach to the management of knee, hip, and shoulder arthritis. Licensed for use in Canada since 1999, this gel-like substance known as hyaluronic acid (HA) is marketed under a variety of names including Durolane, Orthovisc, Synvisc, and Monovisc among others.  

​

When injected into an arthritic joint under guided ultrasound, HA acts as a joint lubricant and a shock absorber. For many clients, an HA injection results in a reduction in joint pain and an improvement in function for approximately 6-9 months. If desired, clients may repeat HA therapy every 6 months on an ongoing basis.

 

While the use of HA therapy alone is often effective, combined injection therapy and HA therapy has been shown to have even better results. In a recent research study comparing outcomes associated with the use of HA, injection therapy or a combination of both, the researchers identified that combined HA and injection therapy results in a more rapid improvement of symptoms.

​

Clients most likely to benefit from a regenerative approach to treatment with combined injection therapy and HA therapy include those with advanced osteoarthritis of the shoulder, hip, and knee.

 

For additional information or to book your in-person or virtual consultation, click the Contact Us  button,  call us at 587.635.3414 or text us at 780.800.9931.